Ding Shi
Impact in
- Hepatology top 2%
- Liver Disease and Transplantation
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
- COVID-19 Clinical Research Studies
Papers in
-
- Gut microbiota and health 17
- Epidemiology 17
- Liver Disease Diagnosis and Treatment 15
- Co-authors
- Daiqiong Fang (28 shared papers)Lanjuan Li (32 shared papers)Wenrui Wu (27 shared papers)Jianzhong Ye (15 shared papers)Longxian Lv (15 shared papers)Yanfei Chen (16 shared papers)Jing Guo (11 shared papers)Feifei Guo (8 shared papers)
- Journals
- Scientific Reports (4 papers)Frontiers in Microbiology (4 papers)World Journal of Gastroenterology (4 papers)Microbial Biotechnology (4 papers)Frontiers in Cellular and Infection Microbiology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ding Shi
49 papers receiving 2.6k citations
Ding Shi's Hit Papers
Peers
Comparison fields: 5 of 118
- Hepatology 295
- Infectious Diseases 422
- Biological Psychiatry 52
- Molecular Biology 1.4k
- Epidemiology 628
Countries citing papers authored by Ding Shi
This map shows the geographic impact of Ding Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Shi more than expected).
Fields of papers citing papers by Ding Shi
This network shows the impact of papers produced by Ding Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Shi. The network helps show where Ding Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Hit paper breakdown → | 2019 | 439 |
| 2 | 2017 | 208 | |
| 3 | 2016 | 194 | |
| 4 | 2018 | 177 | |
| 5 | 2016 | 169 | |
| 6 | 2015 | 132 | |
| 7 | 2021 | 89 | |
| 8 | 2017 | 81 | |
| 9 | 2017 | 78 | |
| 10 | 2016 | 78 | |
| 11 | 2018 | 74 | |
| 12 | 2016 | 70 | |
| 13 | 2020 | 65 | |
| 14 | 2019 | 65 | |
| 15 | 2020 | 61 | |
| 16 | 2020 | 54 | |
| 17 | 2018 | 54 | |
| 18 | 2021 | 51 | |
| 19 | 2004 | 50 | |
| 20 | 2020 | 47 |
About Ding Shi
Ding Shi is a scholar working on Molecular Biology, Epidemiology, Infectious Diseases, Hepatology and Food Science, having authored 52 papers that have together received 2.6k indexed citations. Recurring topics across this work include Gut microbiota and health (17 papers), Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (8 papers), COVID-19 Clinical Research Studies (6 papers), Probiotics and Fermented Foods (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Hepatology (295 citations), Infectious Diseases (422 citations), Biological Psychiatry (52 citations), Molecular Biology (1.4k citations) and Epidemiology (628 citations). Ding Shi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Daiqiong Fang, Lanjuan Li, Wenrui Wu, Jianzhong Ye, Longxian Lv, Yanfei Chen, Jing Guo, Feifei Guo, Yating Li and Xiaoyuan Bian. Their work appears in journals such as Scientific Reports, Frontiers in Microbiology, World Journal of Gastroenterology, Microbial Biotechnology and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.